Book a Demo
Platform Overview
Operations
Operational Impact Deployment & Security Integrations Core Lab Solutions EHR Mining Partnerships
Cardiac Amyloidosis Heart Failure Aortic Stenosis Pulmonary Hypertension Strain Stress Echocardiography
Clinical Evidence Case Studies Testimonials Peer Comparison Authors & Collaborators
News ROI Calculator Reimbursements Regulatory Status Evaluating AI Echo Glossary
Our Story Careers Media Kit Patents Trust Center
Partnerships

Where Us2.ai Fits in Cardiac Care

Us2.ai is vendor-neutral and ships through imaging OEMs, AI platforms, and PACS systems. Academic centers run the research that anchors our clinical evidence. See how each pathway works technically.

Selected partners

See the full list, grouped by integration type, below.

Integrations

Where Us2.ai Is Available

Browse partners by integration type: OEM devices, AI platforms, PACS systems, and distributors.

OEM & device resellers

Bundled with ultrasound device sales

Us2.ai is fully vendor-neutral. The software analyzes echocardiographic images regardless of the ultrasound machine or vendor used, and the partners below are authorized to provide Us2.ai alongside their device sales.

AI platforms

Available through the AI platform you already use

AI marketplaces and care-pathway platforms that distribute Us2.ai inside their offering. Radiology and cardiology departments can deploy through a single platform alongside other validated AI applications.

PACS system integrations

Reports inside the PACS your team reads in

Us2.ai's structured echo reports show up directly in the cardiology reading workflow you already use.

Other distributors

Regional distribution partners

Distribution partners that bring Us2.ai's automated echo analysis to specific regions and customer segments.

Research Highlights

Academic Research Partners

Independent academic centers run the studies that anchor our clinical evidence base.

Duke University

Research partnership

Multi-year research partnership with Duke on AI-enabled echocardiography software.

Read the announcement

Brigham and Women's Hospital

Cardiac Imaging Core Laboratory

Us2.ai provides AI echo diagnosis support for the Cardiac Imaging Core Laboratory at Brigham and Women's Hospital.

Read the announcement

We're also collaborating with additional partners and institutions that can't currently be named due to confidentiality agreements. Our Clinical Evidence page covers further examples of our collaborative and validation work.

Care Pathway

In the Viz.ai ATTR-CM Care Pathway

Us2.ai is selected as the AI echo algorithm in disease-specific care pathways for under-diagnosed cardiac conditions.

Viz.ai ATTR-CM care pathway

Cardiac amyloidosis

The AI echo algorithm in the Viz.ai ATTR-CM care pathway. Built to catch cardiac amyloidosis earlier and route patients into the right downstream care.

See the cardiac amyloidosis pathway
Clinical Coverage

AI Detection Across Disease Areas

Heart Failure

Detect HFrEF, HFmrEF, and HFpEF with accurate, reproducible LVEF, GLS, and diastolic function on every scan.

Cardiac Amyloidosis

FDA-cleared deep-learning detection from a standard echo view, with automated wall thickness, GLS, and apical sparing.

Aortic Stenosis

Automated detection and grading of aortic stenosis severity: Vmax, mean gradient, AVA, and classification.

Pulmonary Hypertension

Detect elevated PA pressure with peak TRV, TAPSE, RA area, and complete RV function assessment.

Strain (GLS)

Detect subclinical dysfunction with vendor-agnostic global longitudinal strain (GLS) from standard 2D echo.

Stress Echocardiography

Detect inducible ischemia with AI wall-motion scoring, bull's-eye mapping, and rest-vs-stress comparison.
Related Pages

Explore More Operations Resources

Operational Impact

See how Us2.ai reduces reporting time by 70% and increases daily scan throughput.

Deployment & Security

Deployment timeline, hardware specs, compliance certifications, and security documentation for your evaluation.

Core Lab Solutions

End-to-end clinical trial echo analysis with automated workflow, QA, and audit logging.

EHR Mining

Mine archived echocardiograms for undetected disease with zero-touch AI retrospective analysis.

Integrations

How Us2.ai plugs into your stack across ultrasound, AI marketplace, PACS, and cloud / API pathways.

ROI Calculator

Model year-one return: additional billable echos, net revenue, ROI, and payback for your practice.

Evaluating AI Echo

A vendor-neutral buyer framework: seven criteria for separating clinical-grade AI echo from automation alone.

Peer Comparison

How AI echocardiography platforms differ: a taxonomy of the market and the questions buyers should ask.

Reimbursements

Echo reimbursement codes, fees, and payment models across 23 markets, with per-country deep dives.

Regulatory Status

Regulatory clearances by market: FDA 510(k), CE MDR, MHRA, TGA, and more, with certificate identifiers.

Clinical Evidence

150+ peer-reviewed studies validating Us2.ai across disease detection, accuracy, and workflow.
Become a Partner

Build with Us2.ai

Imaging vendors, platform providers, pharma teams, and academic researchers. If there's a way to work together, get in touch.

Contact our team